SMH
IOVA icon

Sanders Morris Harris’s Iovance Biotherapeutics IOVA Stock Holding History

Sanders Morris Harris’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,250
Closed -$22.2K – 158
2025
Q3 		$22.2K Buy
+10,250
New +$24.2K ﹤0.01% 301
2025
Q2 		– Sell
-10,250
Closed -$33.3K – 227
2025
Q1 		$33.3K Hold
10,250
– – 0.01% 277
2024
Q4 		$75.8K Sell
10,250
-5,950
-37% -$55.2K 0.01% 276
2024
Q3 		$152K Hold
16,200
– – 0.03% 262
2024
Q2 		$130K Hold
16,200
– – 0.02% 260
2024
Q1 		$240K Hold
16,200
– – 0.04% 228
2023
Q4 		$152K Hold
16,200
– – 0.07% 159
2023
Q3 		$71.6K Hold
16,200
– – 0.01% 246
2023
Q2 		$115K Buy
+16,200
New +$116K 0.03% 239
2023
Q1 		– Sell
-16,200
Closed -$104K – 198
2022
Q4 		$104K Hold
16,200
– – 0.04% 191
2022
Q3 		$152K Hold
16,200
– – 0.04% 254
2022
Q2 		$186K Sell
16,200
-16,200
-50% -$212K 0.04% 257
2022
Q1 		$539K Buy
32,400
+16,200
+100% +$251K 0.11% 154
2021
Q4 		$310K Hold
16,200
– – 0.05% 231
2021
Q3 		$433K Hold
16,200
– – 0.08% 188
2021
Q2 		$415K Hold
16,200
– – 0.08% 199
2021
Q1 		$502K Hold
16,200
– – 0.11% 155
2020
Q4 		$820K Hold
16,200
– – 0.19% 100
2020
Q3 		$518K Buy
+16,200
New +$497K 0.14% 138

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Morris Harris's IOVA Position: Q4 2025 in Review

Sanders Morris Harris sold out of Iovance Biotherapeutics (IOVA) in Q4 2025, closing a stake of 10,250 shares — an estimated $22.2K sold.

Sanders Morris Harris first reported a position in IOVA in Q3 2020 and held it in 19 quarters. The position peaked at $820K in Q4 2020. 263 funds tracked by Wall St. Rank hold IOVA as of Q4 2025.

  • Sanders Morris Harris reported no remaining Iovance Biotherapeutics position as of Q4 2025 after selling out during the quarter.
  • Sanders Morris Harris sold 10,250 Iovance Biotherapeutics shares in Q4 2025, an estimated $22.2K.
  • Sanders Morris Harris first reported a position in Iovance Biotherapeutics in Q3 2020 and held it in 19 quarters.
  • Sanders Morris Harris's Iovance Biotherapeutics position peaked at $820K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2025.

Based on Sanders Morris Harris's 13F filing for Q4 2025, filed 8 Jan 2026.